Sign Out
Hypersensitivity: If allergic or anaphylactic reactions occur, administration of XYNTHA should be stopped immediately and appropriate medical management should be given which may include treatment for shock.
Activity-neutralizing antibodies (inhibitors): If expected factor VIII activity plasma levels are not attained, or if bleeding is not controlled with an appropriate dose, an assay should be performed to determine if a factor VIII inhibitor is present.
